Back to PFE Stock Lookup

Pfizer (PFE) – Press Releases

May 26, 2015 09:00 AM ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV
May 19, 2015 10:00 AM Pfizer Invites Public to View and Listen to Webcast of June 2 Conference Call with Analysts to Review Oncology Business and ASCO Data Presentations
May 14, 2015 12:27 PM Pfizer Receives Request For Additional Information From FTC Regarding Proposed Acquisition Of Hospira
May 14, 2015 08:07 AM Marc Tessier-Lavigne, Ph.D. to Leave Pfizer Board of Directors
May 13, 2015 05:01 PM Merck KGaA, Darmstadt, Germany, and Pfizer to Present Data at ASCO for Avelumab, an Investigational Anti-PD-L1 Antibody
May 11, 2015 04:30 PM Pfizer Acquires Minority Interest in AM-Pharma; Secures Option to Acquire Company
May 6, 2015 12:48 PM Pfizer Appoints New Leaders for BioTherapeutics Research & Development and Rinat
May 6, 2015 08:00 AM Nodality Launches PathPro™ T Cell Receptor (TCR) and B Cell Receptor (BCR) Panels for Assessing Drug Impact on Functional Signaling in Primary Human Cells
May 6, 2015 04:51 AM ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy
Apr 28, 2015 07:30 AM Hospira Reports First-Quarter 2015 Results
Apr 28, 2015 07:00 AM PFIZER REPORTS FIRST-QUARTER 2015 RESULTS
Apr 27, 2015 09:00 AM China Jo-Jo Drugstore Signed a New Sales Incentive Agreement with Wyeth Pharmaceutical, a Subsidiary of Pfizer
Apr 23, 2015 02:07 PM Pfizer Hosts Annual Meeting Of Shareholders
Apr 21, 2015 10:00 AM Pfizer Receives U.S. FDA Breakthrough Therapy Designation For XALKORI® (crizotinib) For The Treatment Of Patients With ROS1-Positive Non-Small Cell Lung Cancer
Apr 21, 2015 08:00 AM Nodality Publishes Study Results Confirming the Company’s Diagnostic Can Predict Induction Therapy Response in Elderly Patients with Acute Myeloid Leukemia
Apr 21, 2015 08:00 AM Pfizer Phase 3 Study Of Inotuzumab Ozogamicin Meets Primary Endpoint In Adult Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia
Apr 20, 2015 08:00 AM Global Strategic Partners Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Phase III Study with Avelumab* in Patients with Stage IIIb/IV Non-Small Cell Lung Cancer
Apr 16, 2015 02:26 PM Pfizer Invites Public to Listen to Webcast of April 23 Annual Meeting of Shareholders
Apr 16, 2015 08:30 AM Pfizer Launches 2014 Integrated Annual Review
Apr 15, 2015 08:00 AM Pfizer Announces PALOMA-3 Trial For IBRANCE® (Palbociclib) Stopped Early Due To Efficacy Seen In Patients With HR+, HER2- Metastatic Breast Cancer Whose Disease Has Progressed Following Endocrine The
Apr 9, 2015 08:00 AM Pfizer Launches First Annual PCSK9 Competitive Grants Program to Advance Cardiovascular Disease Research
Apr 7, 2015 08:00 AM Global Strategic Partners Merck KGaA, Darmstadt, Germany, and Pfizer Finalize Agreement to Co-Promote XALKORI® (crizotinib)
Apr 7, 2015 07:00 AM GlycoMimetics Provides Update on Pfizer’s Plans to Initiate Phase 3 Trial with Rivipansel in Mid-2015
Apr 6, 2015 01:00 PM Kathrin U. Jansen, Ph.D., to Lead Pfizer’s Vaccine Research and Development Unit
Apr 2, 2015 02:30 PM Nodality Launches PathPro™ Chronic Lymphocytic Leukemia (CLL) Panels Based on Leading Single Cell Network Profiling (SCNPTM) Platform to Enhance Pharmaceutical R&D
Mar 30, 2015 11:00 AM Dr. Charles Reay Mackay To Join Pfizer as Chief Scientific Officer, Inflammation and Immunology Research Unit
Mar 26, 2015 10:00 AM Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference
Mar 24, 2015 10:00 AM Pfizer Invites Public To View And Listen To Webcast Of April 28 Conference Call With Analysts
Mar 23, 2015 08:00 AM Pfizer And Lilly Preparing To Resume Phase 3 Chronic Pain Program For Tanezumab
Mar 20, 2015 01:00 PM Pfizer Announces Oral Tofacitinib Meets Primary Endpoints In Pivotal Phase 3 Psoriasis Trials
Mar 18, 2015 05:04 PM Results of Pfizer’s Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA) Published in the New England Journal of Medicine
Mar 18, 2015 10:39 AM Help Protect Texas' Babies: Make sure your children are fully vaccinated
Mar 12, 2015 04:30 PM Pfizer Reports Top-Line Results From A Phase 4 Study Evaluating LYRICA® Capsules CV As A Treatment For Adolescents With Fibromyalgia
Mar 11, 2015 02:34 PM A.M. Best Affirms Ratings of Blue Whale Re Ltd.
Mar 3, 2015 08:35 AM Pfizer Receives European Approval for New Indication for Prevenar 13 for Prevention of Vaccine-Type Pneumococcal Pneumonia in Adults
Feb 26, 2015 12:29 PM CDC Advisory Committee on Immunization Practices Votes to Recommend Serogroup B Meningococcal Disease Vaccination for Persons at Increased Risk
May 19, 2014 08:05 AM Semi-Annual Changes to the NASDAQ OMX CRD Global Sustainability Index
Jan 13, 2014 08:00 AM Portola Pharmaceuticals Enters Second Clinical Collaboration Agreement With Bristol-Myers Squibb and Pfizer to Study Andexanet Alfa* (PRT4445), Investigational Factor Xa Inhibitor Reversal Agent, With

Back to PFE Stock Lookup